No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
BSX250117P81000
- 0.00
- 0.000.00%
15min DelayClose Jan 14 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest81.00Strike Price0.00Turnover0.00%IV15.32%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma212.56Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
CardioFocus Announces Publication of 1-Year ECLIPSE AF Clinical Trial Results
Boston Scientific Expects Farapulse, Watchman to Drive 2025 Growth
Citi Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $107
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors
Why Boston Scientific (BSX) Is Skyrocketing in 2025?
Baird Adjusts Price Target on Boston Scientific $104 From $102, Keeps Outperform Rating